PLYMOUTH MEETING, Pa., Oct. 5 /PRNewswire-FirstCall/ -- Genaera Corporation (Nasdaq: GENR) today announced that the Company will be presenting at two upcoming conferences, Biotech 2007 in Philadelphia on October 8-9, 2007 and the BIO InvestorForum in San Francisco on October 9-11, 2007.
Henry R. Wolfe, Ph.D., Executive Vice President and Chief Scientific Officer of Genaera, is scheduled to participate in a panel session entitled, "Advancing Obesity Therapeutics" to be held at Biotech 2007 at the Loews Philadelphia Hotel in Philadelphia on Tuesday, October 9, 2007.
At BIO InvestorForum in San Francisco, Michael J. Gast, M.D., Ph.D., Executive Vice President and Chief Medical Officer of Genaera, is scheduled to participate as part of an obesity panel entitled, "Obesity Management: The Thick and Thin of New Targets and Treatments." The panel is expected to be held at the Palace Hotel beginning at 9:10 AM PT (12:10 PM ET) on Wednesday, October 10, 2007.
Additionally, Jack Armstrong, President and CEO of Genaera, is scheduled to provide a company overview, also at BIO InvestorForum, at 2:00 PM PT (5:00 PM ET) on Thursday, October 11, 2007.
Genaera Corporation is focused on advancing the science and treatment
of metabolic diseases. The Company has significant market opportunities
with a first-in-class molecule, trodusquemine (MSI-1436), that has the
potential to redefine the treatment paradigm for obesity and type 2
diabetes and is presently in a Phase 1 trial in obesity. In addition,
Genaera has a value- driven, fully out-licensed partnership with MedImmune,
Inc. for a second core program that is presently undergoing Phase 2
clinical testing in asthma. Genaera is committed to dir
|SOURCE Genaera Corporation|
Copyright©2007 PR Newswire.
All rights reserved